Brian Zumbolo Joins the Schreiner Group Team
The experienced manager will head the company’s US plant.
Schreiner Group, who specializes in labels for the pharmaceutical industry, is hiring Brian Zumbolo as the new president of its US plant in Blauvelt, NY. The position had become vacant because the previous manager, Gene Dul, had decided to retire after 15 successful years.
In the past, he has already worked in Schreiner Group's two most important markets, healthcare and mobility, most recently for a supplier in the automotive industry. He has experience in developing new markets, in acquisitions, in driving customer specifications, and in developing strong teams. For six years, he had led the Asia-Pacific business of a major US company from China.
"Schreiner Group has performed very well in the US over the past few years—now, there is the opportunity to take the business to a new level of growth and expansion," says Zumbolo. "I believe Schreiner Group still has great market potential in the United States. In the future, I see our potential as equaling that of the Schreiner Group business in Europe."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
